Autopsy report · NCT03018106

Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction

“Obstacles with recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 months before it started.
• Ran for about 3 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Emory University

Sponsor type

University, hospital or other

Conditions

Sexual Dysfunction, Physiological

Interventions

Ospemifene; Vaginal conjugated estrogens

Participants

1

Sites

4

Countries

United States

Trials that died the same way

• Alzheimer Disease : Rehabilitation's Intervention at Home
  “difficulties of recruitment” (92% match in meaning)
• Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer
  “Problems of recruitment” (92% match in meaning)
• Robotic Decompression of the Pudendal Nerve in Pudendal Neuralgia
  “recruitments difficulties” (91% match in meaning)
• Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.
  “Difficulties in recruitment” (91% match in meaning)
• Neuropsychological Factors Associated With Vulnerability to Suicidal Behavior in Depressed Elderly Patients
  “recruitment difficulties” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.